Detection of BRAFV600E mutation for diagnosis of thyroid cancer is well documented, however studies not always concord regarding the utility of BRAF detection for prognosis and survival of patient with thyroid cancer. This evidence concerns the gene BRAF and thyroid gland carcinoma.